A novel method for counting spontaneous motor activity in the rat

Brain Research Protocols

Volumn 1, Issue 4, 1997, Pages 321-326

  Masuo, Yoshinori ^a,b   Matsumoto, Yoshio ^a   Morita, Shigeru ^a   Noguchi, Jiro ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Behavioral neurobiology; Intracerebroventricular; Pituitary adenylate cyclase activating polypeptide; Rearing behavior; Spontaneous motor activity; Thyrotropin releasing hormone; Vasoactive intestinal polypeptide

Indexed keywords

CENTRAL STIMULANT AGENT; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PROTIRELIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; MAGNETIC FIELD; MALE; MEASUREMENT; MONITORING; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; REARING; SENSOR;

ANIMALS; BEHAVIORAL SCIENCES; EQUIPMENT AND SUPPLIES; EQUIPMENT DESIGN; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SEXUAL BEHAVIOR, ANIMAL;

EID: 0031251788     PISSN: 1385299X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1385-299X(97)00005-6     Document Type: Article

References (13)

1. [1] A. Arimura, S. Shioda, Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction, Front. Neuroendocrinol. 16 (1995) 53-88.
2. [2] P.J. Fray, B.J. Sahakian, T.W. Robbins, G.F. Koob, S.D. Iversen, An observational method for quantifying the behavioural effects of dopamine agonists: contrasting effects of D-amphetamine and apomorphine, Psychopharmacology 69 (1980) 253-259.
3. 3H-dopamine from slices of rat nucleus accumbens in vitro, Br. J. Pharmacol. 67 (1979) 323-325.
4. [4] Y. Masuo, T. Ohtaki, Y. Masuda, M. Tsuda, M. Fujino, Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections, Brain Res. 575 (1992) 113-123.
5. [5] Y. Masuo, Y. Matsumoto, F. Tokito, M. Tsuda, M. Fujino, Effects of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) on the spontaneous release of acetylcholine from the rat hippocampus by brain microdialysis, Brain Res. 611 (1993) 207-215.
6. [6] Y. Masuo, J. Noguchi, S. Morita, Y. Matsumoto, Effects of intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) on the motor activity and reserpine-induced hypothermia in murines, Brain Res. 700 (1995) 219-226.
7. [7] M. Miyamoto, Y. Nagawa, Mesolimbic involvement in the locomotor stimulant action of thyrotropin-releasing hormone (TRH) in rats, Eur. J. Pharmacol. 44 (1977) 143-152.
8. [8] M. Miyamoto, N. Fukuda, S. Narumi, Y. Nagai, Y. Saji, Y. Nagawa, γ-Butyrolactone-γ-carbonyl-histidyl-prolinamide citrate (DN-1417): a novel TRH analog with potent effects on the central nervous system, Life Sci. 28 (1981) 861-869.
9. [9] M. Miyamoto, S. Narumi, Y. Nagai, Y. Saji, Y. Nagawa, A TRH analog (DN-1417): motor stimulation with rearing related to catecholaminergic mechanisms in rats, Neuropharmacology 23 (1984) 61-72.
10. [10] J.E. Morley, M. Horowitz, P.M.K. Morley, J.F. Flood, Pituitary adenylate cyclase activating polypeptide (PACAP) reduces food intake in mice, Peptides 13 (1992) 1133-1135.
11. [11] T. Murase, K. Kondo, K. Otake, Y. Oiso, Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats, Neuroendocrinology 57 (1993) 1092-1096.
12. [12] S. Narumi, Y. Nagai, Y. Saji, Y. Nagawa, A possible mechanism of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats, Jpn. J. Pharmacol. 39 (1985) 425-435.
13. [13] Paxinos, G., Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, Sydney, 1986.